Overview
- Scott Adams said he is declining fast from metastatic prostate cancer and asked President Donald Trump to get Kaiser Permanente of Northern California to schedule an IV infusion of the FDA‑approved therapy Pluvicto.
- Trump responded on Truth Social with "On it," while Health and Human Services Secretary Robert F. Kennedy Jr. publicly asked how to reach Adams to facilitate assistance.
- White House deputy chief of staff Dan Scavino signaled the case was being tracked, with additional outreach noted from administration figures including Dr. Mehmet Oz.
- Kaiser stated Adams’ oncology team is working closely with him and that care steps are underway, adding it has treated more than 150 Northern California patients with Pluvicto since the drug’s 2022 approval.
- Pluvicto is a radioligand therapy administered by IV for PSMA‑positive metastatic prostate cancer, and Novartis recently reported a 28% reduction in risk of progression or death; Adams also posted he was heading to the emergency room and canceled his broadcast.